Copyright Reports & Markets. All rights reserved.

Global Platelet Rich Plasma Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Platelet Rich Plasma Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Platelet Rich Plasma Market Size Growth Rate by Product
      • 1.4.2 P-PRP
      • 1.4.3 L-PRP
      • 1.4.4 L-PRF
    • 1.5 Market by End User
      • 1.5.1 Global Platelet Rich Plasma Market Size Growth Rate by End User
      • 1.5.2 Orthopedic Surgery
      • 1.5.3 Cosmetic Surgery
      • 1.5.4 General Surgery
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Platelet Rich Plasma Market Size
      • 2.1.1 Global Platelet Rich Plasma Revenue 2014-2025
      • 2.1.2 Global Platelet Rich Plasma Sales 2014-2025
    • 2.2 Platelet Rich Plasma Growth Rate by Regions
      • 2.2.1 Global Platelet Rich Plasma Sales by Regions
      • 2.2.2 Global Platelet Rich Plasma Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Platelet Rich Plasma Sales by Manufacturers
      • 3.1.1 Platelet Rich Plasma Sales by Manufacturers
      • 3.1.2 Platelet Rich Plasma Sales Market Share by Manufacturers
      • 3.1.3 Global Platelet Rich Plasma Market Concentration Ratio (CR5 and HHI)
    • 3.2 Platelet Rich Plasma Revenue by Manufacturers
      • 3.2.1 Platelet Rich Plasma Revenue by Manufacturers (2014-2019)
      • 3.2.2 Platelet Rich Plasma Revenue Share by Manufacturers (2014-2019)
    • 3.3 Platelet Rich Plasma Price by Manufacturers
    • 3.4 Platelet Rich Plasma Manufacturing Base Distribution, Product Types
      • 3.4.1 Platelet Rich Plasma Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Platelet Rich Plasma Product Type
      • 3.4.3 Date of International Manufacturers Enter into Platelet Rich Plasma Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Platelet Rich Plasma Sales by Product
    • 4.2 Global Platelet Rich Plasma Revenue by Product
    • 4.3 Platelet Rich Plasma Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Platelet Rich Plasma Breakdown Data by End User

    6 North America

    • 6.1 North America Platelet Rich Plasma by Countries
      • 6.1.1 North America Platelet Rich Plasma Sales by Countries
      • 6.1.2 North America Platelet Rich Plasma Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Platelet Rich Plasma by Product
    • 6.3 North America Platelet Rich Plasma by End User

    7 Europe

    • 7.1 Europe Platelet Rich Plasma by Countries
      • 7.1.1 Europe Platelet Rich Plasma Sales by Countries
      • 7.1.2 Europe Platelet Rich Plasma Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Platelet Rich Plasma by Product
    • 7.3 Europe Platelet Rich Plasma by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Platelet Rich Plasma by Countries
      • 8.1.1 Asia Pacific Platelet Rich Plasma Sales by Countries
      • 8.1.2 Asia Pacific Platelet Rich Plasma Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Platelet Rich Plasma by Product
    • 8.3 Asia Pacific Platelet Rich Plasma by End User

    9 Central & South America

    • 9.1 Central & South America Platelet Rich Plasma by Countries
      • 9.1.1 Central & South America Platelet Rich Plasma Sales by Countries
      • 9.1.2 Central & South America Platelet Rich Plasma Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Platelet Rich Plasma by Product
    • 9.3 Central & South America Platelet Rich Plasma by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Platelet Rich Plasma by Countries
      • 10.1.1 Middle East and Africa Platelet Rich Plasma Sales by Countries
      • 10.1.2 Middle East and Africa Platelet Rich Plasma Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Platelet Rich Plasma by Product
    • 10.3 Middle East and Africa Platelet Rich Plasma by End User

    11 Company Profiles

    • 11.1 Harvest Technologies
      • 11.1.1 Harvest Technologies Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Harvest Technologies Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Harvest Technologies Platelet Rich Plasma Products Offered
      • 11.1.5 Harvest Technologies Recent Development
    • 11.2 DePuy Synthes
      • 11.2.1 DePuy Synthes Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 DePuy Synthes Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 DePuy Synthes Platelet Rich Plasma Products Offered
      • 11.2.5 DePuy Synthes Recent Development
    • 11.3 Stryker
      • 11.3.1 Stryker Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Stryker Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Stryker Platelet Rich Plasma Products Offered
      • 11.3.5 Stryker Recent Development
    • 11.4 Zimmer Biomet
      • 11.4.1 Zimmer Biomet Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Zimmer Biomet Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Zimmer Biomet Platelet Rich Plasma Products Offered
      • 11.4.5 Zimmer Biomet Recent Development
    • 11.5 Arthrex
      • 11.5.1 Arthrex Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Arthrex Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Arthrex Platelet Rich Plasma Products Offered
      • 11.5.5 Arthrex Recent Development
    • 11.6 Exactech
      • 11.6.1 Exactech Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Exactech Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Exactech Platelet Rich Plasma Products Offered
      • 11.6.5 Exactech Recent Development
    • 11.7 Emcyte Corporation
      • 11.7.1 Emcyte Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Emcyte Corporation Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Emcyte Corporation Platelet Rich Plasma Products Offered
      • 11.7.5 Emcyte Corporation Recent Development
    • 11.8 Arteriocyte
      • 11.8.1 Arteriocyte Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Arteriocyte Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Arteriocyte Platelet Rich Plasma Products Offered
      • 11.8.5 Arteriocyte Recent Development
    • 11.9 Adilyfe
      • 11.9.1 Adilyfe Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Adilyfe Platelet Rich Plasma Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Adilyfe Platelet Rich Plasma Products Offered
      • 11.9.5 Adilyfe Recent Development

    12 Future Forecast

    • 12.1 Platelet Rich Plasma Market Forecast by Regions
      • 12.1.1 Global Platelet Rich Plasma Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Platelet Rich Plasma Revenue Forecast by Regions 2019-2025
    • 12.2 Platelet Rich Plasma Market Forecast by Product
      • 12.2.1 Global Platelet Rich Plasma Sales Forecast by Product 2019-2025
      • 12.2.2 Global Platelet Rich Plasma Revenue Forecast by Product 2019-2025
    • 12.3 Platelet Rich Plasma Market Forecast by End User
    • 12.4 North America Platelet Rich Plasma Forecast
    • 12.5 Europe Platelet Rich Plasma Forecast
    • 12.6 Asia Pacific Platelet Rich Plasma Forecast
    • 12.7 Central & South America Platelet Rich Plasma Forecast
    • 12.8 Middle East and Africa Platelet Rich Plasma Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Platelet Rich Plasma Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Platelet Rich Plasma market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Platelet Rich Plasma market based on company, product type, end user and key regions.

      This report studies the global market size of Platelet Rich Plasma in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Platelet Rich Plasma in these regions.
      This research report categorizes the global Platelet Rich Plasma market by top players/brands, region, type and end user. This report also studies the global Platelet Rich Plasma market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Harvest Technologies
      DePuy Synthes
      Stryker
      Zimmer Biomet
      Arthrex
      Exactech
      Emcyte Corporation
      Arteriocyte
      Adilyfe

      Market size by Product
      P-PRP
      L-PRP
      L-PRF
      Market size by End User
      Orthopedic Surgery
      Cosmetic Surgery
      General Surgery
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Platelet Rich Plasma market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Platelet Rich Plasma market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Platelet Rich Plasma companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Platelet Rich Plasma submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Platelet Rich Plasma are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Platelet Rich Plasma market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now